Jan C Buckner Selected Research

Jan C Buckner Research Topics

Disease

62	Neoplasms (Cancer) 01/2022 - 01/2002
29	Glioma (Gliomas) 10/2020 - 06/2002
27	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 12/2003
11	Astrocytoma (Pilocytic Astrocytoma) 07/2019 - 12/2003
9	Brain Neoplasms (Brain Tumor) 01/2018 - 07/2003
9	Neoplasm Metastasis (Metastasis) 01/2017 - 02/2002
8	Oligodendroglioma 07/2019 - 01/2003
5	Fatigue 01/2018 - 02/2006
3	Disease Progression 01/2018 - 05/2011
3	Exanthema (Rash) 06/2011 - 12/2008
3	Diarrhea 06/2011 - 10/2006
3	Vomiting 10/2006 - 02/2002
3	Sarcoma (Soft Tissue Sarcoma) 06/2002 - 01/2002
2	Thrombocytopenia (Thrombopenia) 01/2018 - 02/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017 - 06/2010
2	Medulloblastoma 02/2014 - 01/2003
2	Hemangiopericytoma 05/2011 - 06/2003
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2010 - 01/2002
2	Mucositis 06/2010 - 10/2006
2	Asthenia 06/2010 - 10/2006
2	Ototoxicity 08/2006 - 05/2006
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Hyperglycemia 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Neutropenia 01/2018
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2017
1	Brain Diseases (Brain Disorder) 01/2017
1	Cognitive Dysfunction 07/2016
1	Hypoxia (Hypoxemia) 09/2013
1	Liver Diseases (Liver Disease) 10/2011
1	Hypersensitivity (Allergy) 09/2011
1	Cholangiocarcinoma 05/2011
1	Meningioma (Meningiomas) 05/2011
1	Infections 11/2010
1	Virus Diseases (Viral Diseases) 11/2010

Drug/Important Bio-Agent (IBA)

15	Temozolomide (Temodar)FDA LinkGeneric 10/2019 - 05/2003
9	Lomustine (CCNU)FDA Link 10/2020 - 01/2003
9	Vincristine (Oncovin)FDA LinkGeneric 10/2020 - 01/2003
8	Procarbazine (Matulane)FDA Link 10/2020 - 01/2003
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2006
5	TOR Serine-Threonine KinasesIBA 01/2018 - 12/2004
5	temsirolimus FDA Link 01/2018 - 08/2005
5	Anticonvulsants (Antiepileptic Drugs)IBA 11/2015 - 10/2005
5	Cisplatin (Platino)FDA LinkGeneric 08/2006 - 01/2002
5	Carmustine (FIVB)FDA Link 08/2006 - 06/2002
4	Bevacizumab (Avastin)FDA Link 01/2022 - 09/2013
4	Pharmaceutical PreparationsIBA 01/2018 - 10/2006
4	EnzymesIBA 11/2015 - 10/2005
4	ErbB Receptors (EGF Receptor)IBA 06/2011 - 07/2004
3	Imatinib Mesylate (Gleevec)FDA Link 07/2019 - 06/2010
3	Alkylating AgentsIBA 01/2019 - 05/2003
3	Irinotecan (Camptosar)FDA LinkGeneric 11/2015 - 05/2003
3	lipid-associated sialic acid (LASA)IBA 12/2014 - 02/2006
3	Biological ProductsIBA 09/2011 - 03/2006
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2011 - 01/2002
3	epidermal growth factor receptor VIIIIBA 12/2008 - 07/2004
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 07/2019 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2018 - 07/2004
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 09/2013
2	Vorinostat FDA Link 01/2018 - 04/2009
2	Everolimus FDA Link 09/2015 - 10/2011
2	Etoposide (VP 16)FDA LinkGeneric 03/2011 - 02/2005
2	Ifosfamide FDA LinkGeneric 03/2011 - 02/2002
2	Transaminases (Aminotransferases)IBA 06/2010 - 10/2006
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2008 - 07/2006
2	ParaffinIBA 10/2006 - 07/2004
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2002 - 01/2002
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2002 - 01/2002
1	carotuximabIBA 01/2022
1	amsonic acid (DAS)IBA 01/2022
1	src-Family KinasesIBA 11/2019
1	Dasatinib (BMS 354825)FDA Link 11/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	raf KinasesIBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	O-(6)-methylguanineIBA 10/2017
1	MethyltransferasesIBA 10/2017
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 06/2016
1	Tumor Biomarkers (Tumor Markers)IBA 06/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013
1	Therapeutic UsesIBA 09/2013
1	Gefitinib (Iressa)FDA Link 06/2011
1	Octreotide (Sandostatin)FDA LinkGeneric 05/2011
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/2011
1	Somatostatin Receptors (Somatostatin Receptor)IBA 05/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2011

Therapy/Procedure

41	Radiotherapy 10/2020 - 06/2002
30	Drug Therapy (Chemotherapy) 07/2019 - 01/2002
27	Therapeutics 01/2019 - 02/2002
2	Chemoradiotherapy 03/2014 - 11/2010
2	Adjuvant Chemotherapy 02/2014 - 11/2008
2	Drug Tapering 06/2010 - 10/2006
2	Craniotomy 05/2008 - 10/2005
1	Continuity of Patient Care 01/2022
1	Adjuvant Chemoradiotherapy 10/2020
1	Combination Drug Therapy (Combination Chemotherapy) 04/2016
1	Contraindications 05/2011
1	Antibiotic Prophylaxis 11/2010
1	Neoadjuvant Therapy 08/2010